BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 17679566)

  • 1. High dose ondansetron for reducing motion sickness in highly susceptible subjects.
    Muth ER; Elkins AN
    Aviat Space Environ Med; 2007 Jul; 78(7):686-92. PubMed ID: 17679566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness.
    Levine ME; Chillas JC; Stern RM; Knox GW
    Aviat Space Environ Med; 2000 Nov; 71(11):1111-4. PubMed ID: 11086664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dimenhydrinate on gastric tachyarrhythmia and symptoms of vection-induced motion sickness.
    Muth ER; Jokerst M; Stern RM; Koch KL
    Aviat Space Environ Med; 1995 Nov; 66(11):1041-5. PubMed ID: 8588792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of marezine and dramamine in preventing symptoms of motion sickness.
    Weinstein SE; Stern RM
    Aviat Space Environ Med; 1997 Oct; 68(10):890-4. PubMed ID: 9327113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of phenytoin on vection-induced motion sickness and gastric myoelectric activity.
    Stern RM; Uijtdehaage SH; Muth ER; Koch KL
    Aviat Space Environ Med; 1994 Jun; 65(6):518-21. PubMed ID: 8074624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diazepam as an anti-motion sickness drug.
    McClure JA; Lycett P; Baskerville JC
    J Otolaryngol; 1982 Aug; 11(4):253-9. PubMed ID: 7131636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gender of subjects and experimenter on susceptibility to motion sickness.
    Jokerst MD; Gatto M; Fazio R; Gianaros PJ; Stern RM; Koch KL
    Aviat Space Environ Med; 1999 Oct; 70(10):962-5. PubMed ID: 10519473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of antimotion sickness drugs.
    Wood CD; Manno JE; Wood MJ; Manno BR; Redetzki HM
    Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P6 acupressure increases tolerance to nauseogenic motion stimulation in women at high risk for PONV.
    Alkaissi A; Ledin T; Odkvist LM; Kalman S
    Can J Anaesth; 2005; 52(7):703-9. PubMed ID: 16103382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic investigation of physiological correlates of motion sickness induced by viewing an optokinetic rotating drum.
    Hu S; McChesney KA; Player KA; Bahl AM; Buchanan JB; Scozzafava JE
    Aviat Space Environ Med; 1999 Aug; 70(8):759-65. PubMed ID: 10447048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of manipulating expectations through placebo and nocebo administration on gastric tachyarrhythmia and motion-induced nausea.
    Levine ME; Stern RM; Koch KL
    Psychosom Med; 2006; 68(3):478-86. PubMed ID: 16738082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorpheniramine for motion sickness.
    Buckey JC; Alvarenga D; Cole B; Rigas JR
    J Vestib Res; 2004; 14(1):53-61. PubMed ID: 15156097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motion-sickness medications for aircrew: impact on psychomotor performance.
    Paul MA; MacLellan M; Gray G
    Aviat Space Environ Med; 2005 Jun; 76(6):560-5. PubMed ID: 15945400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness.
    Wood CD; Stewart JJ; Wood MJ; Manno JE; Manno BR; Mims ME
    Aviat Space Environ Med; 1990 Feb; 61(2):157-61. PubMed ID: 2178599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of expectations to motion sickness symptoms and gastric activity.
    Williamson MJ; Thomas MJ; Stern RM
    J Psychosom Res; 2004 Jun; 56(6):721-6. PubMed ID: 15193970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autogenic-feedback training exercise is superior to promethazine for control of motion sickness symptoms.
    Cowings PS; Toscano WB
    J Clin Pharmacol; 2000 Oct; 40(10):1154-65. PubMed ID: 11028255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pre-exposures to a rotating optokinetic drum on adaptation to motion sickness.
    Hu SQ; Stern RM; Koch KL
    Aviat Space Environ Med; 1991 Jan; 62(1):53-6. PubMed ID: 1996932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric arrhythmia and nausea of motion sickness induced in healthy Japanese subjects viewing an optokinetic rotating drum.
    Imai K; Kitakoji H; Sakita M
    J Physiol Sci; 2006 Oct; 56(5):341-5. PubMed ID: 17002813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prophylactic ondansetron on postoperative nausea and vomiting in patients on preoperative steroids undergoing craniotomy for supratentorial tumors.
    Wig J; Chandrashekharappa KN; Yaddanapudi LN; Nakra D; Mukherjee KK
    J Neurosurg Anesthesiol; 2007 Oct; 19(4):239-42. PubMed ID: 17893575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.